|
|
|
|
Serotonin in Gut Linked to Bone Formation
NEW YORK, Nov.26 -- That Thanksgiving turkey may be bad for your bones. That's one of the implications of a study that -- for the first time -- links the gut to bone formation, according to Gerard Karsenty, M.D., Ph. D., of the...
|
|
|
Eli Lilly and Company (LLY) (JOBS) Pulls FDA Application for Cymbalta for Pain
INDIANAPOLIS, Nov.28 /PRNewswire-FirstCall/ -- (NYSE: LLY - News) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta (duloxetine HCl) for the management of chronic...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta for Chronic Pain
Resubmission to FDA Planned for First Half of 2009 with Additional Data INDIANAPOLIS, November 28, 2008 /PRNewswire-FirstCall/ -- Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S.Food and Drug...
|
|
|
Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain
Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S.Food and Drug Administration (FDA) for Cymbalta (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application...
|
|
|
Eli Lilly and Company withdraws sNDA for additional US indication for Cymbalta for chronic pain
(M2 EQUITYBITES via COMTEX) -- LLY | Quote | Chart | News | PowerRating -- Eli Lilly and Company (NYSE: LLY), a provider of a portfolio ofApharmaceutical products, said on 28 November that it has withdrawn its supplemental New Drug...
|
|
|
5-HTT promoter variant linked to antidepressant-associated mania
J Affect Dis 2009: 112: 267272 MedWire News: A polymorphism in the serotonin transporter gene promoter region (5-HTTLPR) predicts the development of antidepressant-associated mania in bipolar disorder patients, but only in the absence...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
INDIANAPOLIS, Nov.28 /PRNewswire-FirstCall/ -- Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of...
|
|
|
Lilly Withdraws Application For Additional U.S. Indication For Cymbalta(R) For Chronic Pain
Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S.Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Resubmission to FDA Planned for First Half of 2009 with Additional Data INDIANAPOLIS, Nov.28 /PRNewswire-FirstCall/ -- Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug...
|
|
|
Mechanism Linking Serotonin With Regulation Of Food Intake Revealed By Research
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Obesity / Weight Loss / Fitness News Main Category: Obesity / Weight Loss / Fitness Also Included In: Neurology / Neuroscience; Biology / Biochemistry; Genetics...
|
|
|
The Gut Implicit In Bone Formation, Study Finds
Bones / Orthopaedics News Main Category: Bones / Orthopaedics Also Included In: Biology / Biochemistry; GastroIntestinal / Gastroenterology; Genetics email to a friend printer friendly view / write opinions rate article Current Article...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Resubmission to FDA Planned for First Half of 2009 with Additional Data INDIANAPOLIS, Nov.28 /PRNewswire-FirstCall/ -- Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Resubmission to FDA Planned for First Half of 2009 with Additional Data INDIANAPOLIS, Nov.28 /PRNewswire-FirstCall/ -- Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug...
|
|
|
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Eli Lilly and Company logo.(PRNewsFoto) INDIANAPOLIS, IN UNITED STATES Resubmission to FDA Planned for First Half of 2009 with Additional Data INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) has...
|
|
|
Combined strategy offers quick HIT diagnosis
MedWire News: Heparin-induced thrombocytopenia (HIT) may be promptly diagnosed using clinical score and an immunoassay, say researchers who believe the combined strategy could avoid unnecessary treatment changes.Although HIT can be...
|
|
|
Discovery of mechanism linking serotonin with regulation of food intake
Medical Research News Genetic mouse models have provided surprising insight into mechanisms linking serotoninergic compounds with the regulation of feeding behavior and body weight.The research, published by Cell Press in the November...
|
|
|
Researchers Find Clue To Safer Obesity Drugs
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions.Scientists at UT Southwestern Medical Center are trying to...
|
|
|
Gut found to exert control over bone
Medical Research News When it comes to remodeling our bones-an ongoing process of break down and renewal that goes on throughout adulthood--researchers have new evidence that our guts play a surprisingly important role.The findings point...
|
|
|
Investigators at Central South University, Mental Health Institute zero in on obstructive sleep apnea genetics
Current study results from the report, 'Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population,' have been published.'Since the serotonin (5-HT) is...
|
|
|
Research reveals mechanism linking serotonin with regulation of food intake
Genetic mouse models have provided surprising insight into mechanisms linking serotoninergic compounds with the regulation of feeding behavior and body weight.The research, published by Cell Press in the November 26th issue of the journal...
|
|
|
Guts Grow Bones
The team was able to prevent osteoporosis in mice undergoing menopause by shutting off the intestines release of serotonin.Most current osteoporosis drugs prevent the breakdown of old bone, but do not create new bone. This new...
|
|
|
It takes guts to build bone, Columbia scientists discover
NEW YORK Bone growth is controlled in the gut through serotonin, the same naturally present chemical used by the brain to influence mood, appetite and sleep, according to a new discovery from researchers at.Until now, the skeleton...
|
|
|
Researchers Find Clue to Safer Obesity Drugs
Newswise Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions.Scientists at are trying to understand how Fen-phen...
|
|
|
Bone formation goes with the gut, study finds
When it comes to remodeling our bonesan ongoing process of break down and renewal that goes on throughout adulthood--researchers have new evidence that our guts play a surprisingly important role.The findings point toward novel methods...
|
|
|
Role of Variation in the Serotonin Transporter Protein Gene (SLC6A4) in Trait Disturbances in the Ventral Ante
_ Role of Variation in the Serotonin Transporter Protein Gene (SLC6A4) in Trait Disturbances in the Ventral Ante.
|
